Clinical update: substance P antagonists in patients with major depression

被引:0
|
作者
Kramer, MS
机构
[1] Univ Penn, Philadelphia, PA 19104 USA
[2] Merck Res Labs, W Point, PA USA
关键词
D O I
暂无
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
引用
收藏
页码:10S / 10S
页数:1
相关论文
共 50 条
  • [1] Update on substance P (NK-1 receptor) antagonists in clinical trials for depression
    Kramer, MS
    NEUROPEPTIDES, 2000, 34 (05) : 255 - 255
  • [2] Substance P (NK-1 receptor) antagonists in major depression
    Krishnan, KRR
    Kramer, MS
    BIOLOGICAL PSYCHIATRY, 2002, 51 (08) : 155S - 155S
  • [3] Clinical experience with substance P receptor (NK1) antagonists in depression
    Krishnan, KRR
    JOURNAL OF CLINICAL PSYCHIATRY, 2002, 63 : 25 - 29
  • [4] Clinical profile of substance P antagonists
    Kramer, MS
    Cutler, NR
    Feighner, J
    Shrivastava, R
    Carman, JS
    Liu, G
    Snavely, D
    Wyatt-Knowles, E
    Reines, SA
    Rupnaik, NM
    BIOLOGICAL PSYCHIATRY, 2000, 47 (08) : 11S - 11S
  • [5] Substance P antagonists: novel agents in the treatment of depression
    Argyropoulos, SV
    Nutt, DJ
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2000, 9 (08) : 1871 - 1875
  • [6] Substance P antagonists: the next breakthrough in treating depression?
    Baby, S
    Nguyen, M
    Tran, D
    Raffa, RB
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 1999, 24 (06) : 461 - 469
  • [7] Substance-P antagonists: a new treatment for depression?
    Nutt, D
    LANCET, 1998, 352 (9141): : 1644 - 1646
  • [8] An update on NMDA antagonists in depression
    Pochwat, Bartlomiej
    Nowak, Gabriel
    Szewczyk, Bernadeta
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2019, 19 (11) : 1055 - 1067
  • [9] Substance P antagonists
    Gorman, J
    JOURNAL OF AFFECTIVE DISORDERS, 2004, 78 : S10 - S10
  • [10] Major depression in patients with HIV/AIDS and substance abuse
    Berger-Greenstein, Jori A.
    Cuevas, Carlos A.
    Brady, Stephen M.
    Trezza, Glenn
    Richardson, Mark A.
    Keane, Terence M.
    AIDS PATIENT CARE AND STDS, 2007, 21 (12) : 942 - 955